Da Hai Xu
Président chez Beijing Tri Prime Gene Pharmaceutical Co., Ltd.
Profil
Da Hai Xu is currently the Chairman-Supervisory Board at Beijing Tri Prime Gene Pharmaceutical Co., Ltd.
Xu has a Master's in Business Administration from Shanghai Advanced Institute of Finance and an undergraduate degree from Fuyang Normal University.
Postes actifs de Da Hai Xu
| Sociétés | Poste | Début |
|---|---|---|
Beijing Tri Prime Gene Pharmaceutical Co., Ltd.
 Beijing Tri Prime Gene Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Tri Prime Gene Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of biomedicine. Its key products include human interferon a1b for injection, human interferon a1b injection, human interferon a1b eye drops, and recombinant human interferon a1b spray. The company was founded by Yun De Hou and Yong Qing Cheng on September 24, 1992 and is headquartered in Beijing, China. | Président | - |
Formation de Da Hai Xu
| Shanghai Advanced Institute of Finance | Masters Business Admin |
| Fuyang Normal University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
 | Health Technology |
